The center will apply genomic approaches to develop more effective therapies for rheumatoid arthritis and lupus. The center will have an estimated 20 scientists, led by Lionel B. Ivashkiv, MD, director, and Shiaoching Gong, PhD, co-director.
More Articles on Genomics:
Roswell Park Cancer Institute Now a Member of New York Genome Center
Boston Children’s Hospital Takes Stake in For-Profit Genomics Company
Brigham and Women’s, Dana-Farber Launch Research Project for Cancer Genomics
